How does CJC-1295 (No DAC) work?
Research overview of how CJC-1295 (No DAC) works at the molecular level — its proposed mechanism of action, what the published research shows, and where the gaps are.
Proposed mechanism of CJC-1295 (No DAC)
A GHRH analogue (Mod GRF 1-29) researched for pulsatile growth hormone release with a shorter duration than the DAC variant.
Research on CJC-1295 (No DAC) focuses on how the peptide interacts with specific biological targets in vitro and in laboratory animal models. Because CJC-1295 (No DAC) is sold strictly for research use, the mechanism is discussed here only in the context of published scientific literature — not as any suggestion of human efficacy.
What the research literature describes
What is the difference between CJC-1295 with and without DAC?
Without DAC has a shorter half-life and produces pulsatile GH release (more natural pattern). With DAC has an extended half-life for sustained GH elevation.
Researchers working with CJC-1295 (No DAC) typically combine multiple analytical techniques — HPLC for purity, mass spectrometry for identity confirmation, and sometimes NMR for structural verification — before beginning any experimental protocol.
Important research limitations
Most published research on novel peptides is preclinical: conducted in cell lines, tissue samples, or animal models. Results from preclinical research do not automatically translate to human outcomes, and no peptide sold for research use is a substitute for an MHRA-approved medicine. All Peptify products are "for research use only" per UK regulations.
Buy CJC-1295 (No DAC) for research
99%+ HPLC-verified CJC-1295 (No DAC) in stock. Every vial ships from the UK with a batch-specific Certificate of Analysis. Same-day dispatch on orders before 1pm.
Frequently asked questions
What is the difference between CJC-1295 with and without DAC?
Without DAC has a shorter half-life and produces pulsatile GH release (more natural pattern). With DAC has an extended half-life for sustained GH elevation.